Healthcare / Health Information ServicesHKSE
$19.94
-4.22 (-17.47%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $57.2M · quality 60.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
12/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.1B
P/E
395.8x
↑EV/EBITDA
58.2x
↑ROE
-0.9%
↓Gross Margin
38.3%
↓Debt/Equity
-0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2024 · 2 años de histórico normalizado
Revenue CAGR
+54.9%
FCF CAGR
+20.3%
FCF margin
8.8%
FCF / Net income
7.96x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $945.0M · net income $10.4M · FCF $82.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $945.0M | $945.0M | $490.0M | $393.6M |
| Net Income | $10.4M | $10.4M | $73.6M | $-2.1M |
| EBITDA | $64.5M | $64.5M | $147.7M | $152.5M |
| EPS | 0.05 | 0.05 | 0.36 | -0.01 |
| Gross Margin | 38.3% | 38.3% | 79.9% | 82.6% |
| Operating Margin | 6.3% | 6.3% | 29.2% | 37.3% |
| Net Margin | 1.1% | 1.1% | 15.0% | -0.5% |
| Balance Sheet | ||||
| Debt/Equity | -0.00 | -0.00 | -0.00 | -0.01 |
| Current Ratio | 6.36 | 6.36 | — | — |
| Cash Flow | ||||
| Free Cash Flow | $82.8M | $82.8M | $7.7M | $57.2M |
| Returns | ||||
| ROE | -0.9% | -0.9% | -6.1% | 0.2% |
| Valuation | ||||
| P/E | 395.76 | 395.76 | — | — |
| EV/EBITDA | 58.18 | 58.18 | — | — |
| Growth & Yield | ||||
| Revenue Growth | 92.9% | 92.9% | 24.5% | — |
| EPS Growth | -85.9% | -85.9% | 3673.2% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
227.5%
EPS terminal req.
$1.77
Spread vs growth
-313.4%
5Y implied EPS CAGR
111.7%
EPS terminal req.
$2.14
Spread vs growth
-197.6%
10Y implied EPS CAGR
52.6%
EPS terminal req.
$3.45
Spread vs growth
-138.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-66.0%
Start / end P/E
164.5x → 395.8x
EPS bridge
0.36 → 0.05
Residual
-120.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.